Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Serroyen

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Nature Communications|November 14, 2024
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primatesAneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.
NPJ Vaccines|December 18, 2020
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidateRamon Roozendaal, Jenny Hendriks, Thierry van Effelterre, et al.
Nature Communications|October 8, 2021
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaquesRamon Roozendaal, Laura Solforosi, Daniel J Stieh, et al.
Nature|December 14, 2023
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaquesKatherine McMahan, Frank Wegmann, Malika Aid, et al.
NPJ Vaccines|March 20, 2021
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory diseaseJoan E M van der Lubbe, Sietske K Rosendahl Huber, Aneesh Vijayan, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Nature Communications|November 14, 2024
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primatesAneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.
NPJ Vaccines|December 18, 2020
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidateRamon Roozendaal, Jenny Hendriks, Thierry van Effelterre, et al.
Nature Communications|October 8, 2021
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaquesRamon Roozendaal, Laura Solforosi, Daniel J Stieh, et al.
Nature|December 14, 2023
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaquesKatherine McMahan, Frank Wegmann, Malika Aid, et al.
NPJ Vaccines|March 20, 2021
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory diseaseJoan E M van der Lubbe, Sietske K Rosendahl Huber, Aneesh Vijayan, et al.
Pageof 5